MedPath

Mole removal with the help of shankadrava liquid.

Phase 2
Not yet recruiting
Conditions
Other hypertrophic disorders of the skin. Ayurveda Condition: MASHAKAH,
Registration Number
CTRI/2025/06/088287
Lead Sponsor
Department of Shalyatantra Shree Saptashrungi Ayurved Mahavidyalaya
Brief Summary

This is a Phase I/II single-arm clinical trial aimed at evaluating the efficacy and safety of Shankhadrava, an Ayurvedic preparation, in the management of Mashaka (moles). The study will assess the potential of Shankhadrava to remove moles from their base and prevent recurrence through its cauterizing and detoxifying properties. A total of 40 eligible participants, aged 18–40 years, presenting with Mashaka will receive topical application of Shankhadrava for a maximum of 21 days. The trial will monitor changes in mole characteristics (size, color, elevation, texture), recurrence, and any adverse effects. The findings may provide a natural, cost-effective alternative to modern mole removal techniques.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria
  • a)Individuals of mashaka(mole) having hard, painless, black and Elevated eruption on the body (skin) resembling the masha (pulse) in shape.
  • b)Sites:-face (except eyelids),legs, back,chest,neck,groin region c)Patients in the age group of 18 to 40 years.
  • d)Patients will be selected irrespective of sex, religion, socio – economic status etc.
Exclusion Criteria
  • 1)The patient age group is less than 18 and more than 40 years.(Baal,vruddha,Durbal,pregnant women also) 2)Tilkalaka of shuk roga.
  • 3)Patient suffering from any other skin disorders like psoriasis, dermatitis, vitiligo, melasma, malignant melanoma and acne.
    1. Patient having chronic infectious diseases like Koch’s, leprosy, Hypersensitivity, cancer and diabetes.
  • 5)Contraindicated to Shankhadrava application Raktapitta (bleeding disorders) ,Timira (eye disease), Moorchha (unconscious), Sira (head), Snayu (tendons), Sandhi (joints), Tarunasthi (ligament bones), Dhamani.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
effect of shankhadrava drops application in mashaka removal from its base and to check its recurrence.21 days
Secondary Outcome Measures
NameTimeMethod
Adverse effect of Shankhadrava application.mole characteristics from modern perspective.

Trial Locations

Locations (1)

Department Of Shalyatanta,Shree Saptashrungi Ayurved Mahavidyalaya And Hospital

🇮🇳

Nashik, MAHARASHTRA, India

Department Of Shalyatanta,Shree Saptashrungi Ayurved Mahavidyalaya And Hospital
🇮🇳Nashik, MAHARASHTRA, India
Dr Hrishikesh Vishnu Kolhe
Principal investigator
7775810624
hrishkolhe2017@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.